Astrid Ruefli-Brasse

1.0k citations
11 papers · 643 indexed · h-index 8
Topics
Cell death mechanisms and regulation (2 papers)Immune Response and Inflammation (2 papers)Protease and Inhibitor Mechanisms (2 papers)

In The Last Decade

Astrid Ruefli-Brasse

10 papers receiving 638 citations

Peers

Astrid Ruefli-Brasse
Comparison fields: 5 of 81
  • Immunology 314
  • Cancer Research 302
  • Molecular Biology 293
  • Oncology 173
  • Pulmonary and Respiratory Medicine 59
Replace Svenja Debey‐Pascher with:
Svenja Debey‐Pascher Germany
Yi Zeng China
Rosa Conforti France
Alexander Polyzos Greece
Qing Tong China
Daniel Vodák Norway
Ariel Raybuck United States
Carol M. Amato United States
Ping Zhu China
Astrid Ruefli-Brasse relative to Svenja Debey‐Pascher Germany Svenja Debey‐Pascher's profile →
Citations per field
00.5×1.7×
Svenja Debey‐Pascher · 1×
Citations per year

Countries citing papers authored by Astrid Ruefli-Brasse

Since Specialization
Citations

This map shows the geographic impact of Astrid Ruefli-Brasse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Astrid Ruefli-Brasse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Astrid Ruefli-Brasse more than expected).

Fields of papers citing papers by Astrid Ruefli-Brasse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Astrid Ruefli-Brasse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Astrid Ruefli-Brasse. The network helps show where Astrid Ruefli-Brasse may publish in the future.

Co-authorship network of co-authors of Astrid Ruefli-Brasse

This figure shows the co-authorship network connecting the top 25 collaborators of Astrid Ruefli-Brasse. A scholar is included among the top collaborators of Astrid Ruefli-Brasse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Astrid Ruefli-Brasse. Astrid Ruefli-Brasse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1 0
2 63
3 3
4 55
5 23
6 2
7 85
8 8
9 31
10 77
11 296

About Astrid Ruefli-Brasse

Astrid Ruefli-Brasse is a scholar working on Cancer Research, Immunology and Molecular Biology, having authored 11 papers that have together received 643 indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (2 papers), Immune Response and Inflammation (2 papers) and Protease and Inhibitor Mechanisms (2 papers). The work is most often cited by research in Cancer Research (302 citations), Immunology (314 citations) and Oncology (173 citations). Astrid Ruefli-Brasse has collaborated with scholars based in United States, Switzerland and Australia. Frequent co-authors include Vishva M. Dixit, Dorothy French, John C. Reed, Wyne P. Lee, Stephen Hurst, Olivier Nolan-Stevaux, Dineli Wickramasinghe, Wendy Zhong, Joe Hoover and Nadège Pelletier. Their work appears in journals such as Science, Journal of Biological Chemistry and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026